Edwards Lifesciences Shares (Basic) decreased by 0.9% to 579.2M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 1.3%, from 586.9M to 579.2M.
A decreasing trend typically signals an aggressive share buyback program, which can increase the value of remaining shares.
Weighted-average shares outstanding (basic) is the calculation of the total number of common shares held by the public d...
Used to evaluate the scale of a company's equity base relative to its market capitalization and peer group.
weighted_shares_basic| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 622.3M | 623.6M | 622.1M | 620.9M | 619.8M | 607.5M | 606.9M | 607M | 601.6M | 602.1M | 597.2M | 586.9M | 587M | 584.7M | 579.2M |
| QoQ Change | — | +0.2% | -0.2% | -0.2% | -0.2% | -2.0% | -0.1% | +0.0% | -0.9% | +0.1% | -0.8% | -1.7% | +0.0% | -0.4% | -0.9% |
| YoY Change | — | — | — | -0.2% | -0.6% | -2.3% | -2.3% | -2.1% | -1.0% | -0.8% | -1.6% | -2.4% | -2.5% | -2.1% | -1.3% |